288 related articles for article (PubMed ID: 15856070)
1. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
[TBL] [Abstract][Full Text] [Related]
2. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
[TBL] [Abstract][Full Text] [Related]
3. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
Yilmaz H; Isbir T; Agachan B; Karaali ZE
Cell Biochem Funct; 2005; 23(1):23-8. PubMed ID: 15386541
[TBL] [Abstract][Full Text] [Related]
4. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.
Boekholdt SM; Sacks FM; Jukema JW; Shepherd J; Freeman DJ; McMahon AD; Cambien F; Nicaud V; de Grooth GJ; Talmud PJ; Humphries SE; Miller GJ; Eiriksdottir G; Gudnason V; Kauma H; Kakko S; Savolainen MJ; Arca M; Montali A; Liu S; Lanz HJ; Zwinderman AH; Kuivenhoven JA; Kastelein JJ
Circulation; 2005 Jan; 111(3):278-87. PubMed ID: 15655129
[TBL] [Abstract][Full Text] [Related]
5. Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin.
Marschang P; Sandhofer A; Ritsch A; Fiŝer I; Kvas E; Patsch JR
J Intern Med; 2006 Aug; 260(2):151-9. PubMed ID: 16882279
[TBL] [Abstract][Full Text] [Related]
6. Taq1B polymorphism of CETP gene on lipid abnormalities in patients with type II diabetes mellitus.
Yilmaz H; Agachan B; Karaali ZE; Isbir T
Int J Mol Med; 2004 Jun; 13(6):889-93. PubMed ID: 15138631
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein TaqIB polymorphism and its relation to parameters of the insulin resistance syndrome in an Austrian cohort.
Weitgasser R; Galvan G; Malaimare L; Derflinger I; Hedegger M; Lang J; Iglseder B; Ladurner G; Paulweber B
Biomed Pharmacother; 2004 Dec; 58(10):619-27. PubMed ID: 15589073
[TBL] [Abstract][Full Text] [Related]
8. An interaction between the TaqIB polymorphism of cholesterol ester transfer protein and smoking is associated with changes in plasma high-density lipoprotein cholesterol levels in Turks.
Hodoğlugil U; Williamson DW; Huang Y; Mahley RW
Clin Genet; 2005 Aug; 68(2):118-27. PubMed ID: 15996208
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer protein B1B1 genotype is associated with a parental history of cardiovascular diseases in Taiwanese people.
Hsieh MC; Chen CC; Wang JY; Chong IW; Yhe CJ; Shin SJ; Lin SR
Med Princ Pract; 2008; 17(2):143-8. PubMed ID: 18287799
[TBL] [Abstract][Full Text] [Related]
10. Comparison of incidences of cardiovascular events among new users of different statins: a retrospective observational cohort study.
Heintjes EM; Penning-van Beest FJ; Johansson S; Stalenhoef AF; Herings RM
Curr Med Res Opin; 2009 Nov; 25(11):2621-9. PubMed ID: 19743959
[TBL] [Abstract][Full Text] [Related]
11. The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.
Kuivenhoven JA; Jukema JW; Zwinderman AH; de Knijff P; McPherson R; Bruschke AV; Lie KI; Kastelein JJ
N Engl J Med; 1998 Jan; 338(2):86-93. PubMed ID: 9420339
[TBL] [Abstract][Full Text] [Related]
12. Effects of cholesteryl ester transfer protein TAQ1B polymorphism in renal transplant patients.
Zeybek U; Isbir T; Ergen HA; Yilmaz H; Hekim N; Akoglu E
Transplant Proc; 2006 Jun; 38(5):1382-4. PubMed ID: 16797310
[TBL] [Abstract][Full Text] [Related]
13. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
[TBL] [Abstract][Full Text] [Related]
14. Association between cholesteryl ester transfer protein gene polymorphisms and variations in lipid levels in patients with coronary heart disease.
Zheng KQ; Zhang SZ; He Y; Zhang L; Zhang KL; Huang DJ; Sun Y
Chin Med J (Engl); 2004 Sep; 117(9):1288-92. PubMed ID: 15377415
[TBL] [Abstract][Full Text] [Related]
15. [Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetes mellitus].
Jiang T; Song XX; Zhang M; Qi WH; Zhang XW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):298-301. PubMed ID: 15952120
[TBL] [Abstract][Full Text] [Related]
16. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic study of apolipoprotein E, cholesteryl ester transfer protein and hepatic lipase genes and simvastatin therapy in Brazilian subjects.
Fiegenbaum M; da Silveira FR; Van der Sand CR; Van der Sand LC; Ferreira ME; Pires RC; Hutz MH
Clin Chim Acta; 2005 Dec; 362(1-2):182-8. PubMed ID: 16038892
[TBL] [Abstract][Full Text] [Related]
18. The CETP TaqIB polymorphism is associated with the risk of sudden death in type 2 diabetic patients.
Porchay-Baldérelli I; Péan F; Bellili N; Jaziri R; Marre M; Fumeron F;
Diabetes Care; 2007 Nov; 30(11):2863-7. PubMed ID: 17666459
[TBL] [Abstract][Full Text] [Related]
19. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
[TBL] [Abstract][Full Text] [Related]
20. [Study on the distribution and association of cholesteryl ester transfer protein-TaqIB polymorphism and plasma concentration in general population].
Liu J; Zhao D; Liu S; Liu J; Qin LP; Wu ZS
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Apr; 24(4):300-3. PubMed ID: 12820950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
